Tracking Results of Ablations to Combat AF Registry Generation 2
ConditionAtrial Fibrillation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAtriCure, Inc.
About this trial
The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.
Eligibility criteria
Qualifiers
Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s)
Patient is willing to provide informed consent
Patient whose age is 18 years or above, or of legal age to give informed consent specific to state and national law
Disqualifiers
None
Trial design
Treatments tested in this trial
- Open Concomitant Surgical Ablation Procedures
- Hybrid (Convergent) Ablation Procedures
- AtriCure Hybrid Totally Thoracoscopic Ablation Procedures
- AtriCure LAA Exclusion Procedures
Treatment groups
No treatment groups listed
Locations
29Austria
Medical University of Vienna Vienna Austria
Canada
Nova Scotia Health AuthorityB3H3A7, HalifaxNova Scotia, Canada
Waterloo Regional Health NetworkN2M1B2, KitchenerOntario, Canada
United States
Alabama
Huntsville Hospital35801, Huntsville United States
Sponsors and collaborators
AtriCure, Inc.
Lead sponsor
Source ClinicalTrials.gov